BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1776754)

  • 1. Characterization of an experimental autoimmune dementia model in the rat.
    Michaelson DM; Alroy G; Goldstein D; Chapman J; Feldon J
    Ann N Y Acad Sci; 1991; 640():290-4. PubMed ID: 1776754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased density of forebrain cholinergic neurons and disintegration of the spatial organization of behavior in experimental autoimmune dementia (EAD).
    Michaelson DM; Dubovik V; Faigon M; Eilam D; Feldon J
    Ann N Y Acad Sci; 1993 Sep; 695():244-8. PubMed ID: 8239291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.
    Oron L; Dubovik V; Novitsky L; Eilam D; Michaelson DM
    J Neural Transm Suppl; 1997; 49():77-84. PubMed ID: 9266416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.
    Chapman J; Alroy G; Weiss Z; Faigon M; Feldon J; Michaelson DM
    Neuroscience; 1991; 40(2):297-305. PubMed ID: 2027463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia.
    Dubovik V; Faigon M; Feldon J; Michaelson DM
    Neuroscience; 1993 Sep; 56(1):75-82. PubMed ID: 8232919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.
    Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
    J Neurosci; 1989 Aug; 9(8):2710-7. PubMed ID: 2475591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disintegration of the spatial organization of behavior in experimental autoimmune dementia.
    Eilam D; Szechtman H; Faigon M; Dubovik V; Feldon J; Michaelson DM
    Neuroscience; 1993 Sep; 56(1):83-91. PubMed ID: 8232920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibodies to cholinergic neurons in Alzheimer's disease.
    Michaelson DM; Chapman J; Bachar O; Korczyn AD; Wertman E
    Prog Clin Biol Res; 1989; 317():689-94. PubMed ID: 2602432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
    Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
    Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.
    Soussan L; Tchernakov K; Bachar-Lavi O; Yuvan T; Wertman E; Michaelson DM
    Mol Neurobiol; 1994; 9(1-3):83-91. PubMed ID: 7888108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons.
    Faigon M; Hadas E; Alroy G; Chapman J; Auerbach JM; Michaelson DM
    J Neurosci Res; 1991 Aug; 29(4):490-8. PubMed ID: 1791640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of rats with cholinergic neurons induces behavioral deficits.
    Chapman J; Feldon J; Alroy G; Michaelson DM
    J Neural Transplant; 1989; 1(2):63-76. PubMed ID: 2519521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with cholinergic cell bodies induces histopathological changes in rat brains.
    Michaelson DM; Kadar T; Weiss Z; Chapman J; Feldon J
    Mol Chem Neuropathol; 1990; 13(1-2):71-80. PubMed ID: 2095784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem auditory evoked potentials in experimental autoimmune dementia.
    Werber EA; Chapman J; Arlazoroff A
    Neurosci Lett; 1993 Mar; 151(2):234-6. PubMed ID: 8506086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cognitive deficits by immunization with cholinergic cell bodies: the influence of age and integrity of the blood-brain barrier.
    Alroy G; Chapman J; Feldon J; Michaelson DM
    J Basic Clin Physiol Pharmacol; 1991; 2(3):197-205. PubMed ID: 1797094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
    Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
    Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to cholinergic neurons in Alzheimer's disease.
    Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
    J Neurochem; 1988 Aug; 51(2):479-85. PubMed ID: 3292704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.